Therapeutic effect of multiple functional minicircle vector encoding anti-CD25/IL-10/CXCR3 in allograft rejection model

키워드

참고문헌 (51)

1. Hariharan S, "Improved graft survival after renal transplantation in the United States, 1988 to 1996", N Engl J Med, 342, pp.605~612 (2000)
2. Meier-Kriesche HU, "Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era", Am J Transplant, 4, pp.378~383 (2004)
3. Bunnapradist S, "Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants : a multivariate analysis of the UNOS database", J Am Soc Nephrol, 14, pp.208~213 (2003)
4. Grenda R, "Biologics in renal transplantation", Pediatr Nephrol, 30, pp.1087~1098 (2015)
5. Parlakpinar H, "Transplantation and immunosuppression : a review of novel transplant-related immunosuppressant drugs", Immunopharmacol Immunotoxicol, 43, pp.651~665 (2021)
6. Lu RM, "Development of therapeutic antibodies for the treatment of diseases", J Biomed Sci, 27, pp.1~ (2020)
7. Chan AC, "Therapeutic antibodies for autoimmunity and inflammation", Nat Rev Immunol, 10, pp.301~316 (2010)
8. McInnes IB, "Cytokines in the pathogenesis of rheumatoid arthritis", Nat Rev Immunol, 7, pp.429~442 (2007)
9. Chen ZY, "Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo", Mol Ther, 8, pp.495~500 (2003)
10. Chen ZY, "Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo", Hum Gene Ther, 16, pp.126~131 (2005)
11. Gill DR, "Progress and prospects : the design and production of plasmid vectors", Gene Ther, 16, pp.165~171 (2009)
12. Gracey Maniar LE, "Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level", Mol Ther, 21, pp.131~138 (2013)
13. Zuo Y, "Minicircle-oriP-IFNγ : a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma", PLoS One, 6, pp.e19407~ (2011)
14. Rim YA, "Self in vivo production of a synthetic biological drug CTLA4Ig using a minicircle vector", Sci Rep, 4, pp.6935~ (2014)
15. Osborn MJ, "Minicircle DNAbased gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type I", Mol Ther, 19, pp.450~460 (2011)
16. Huang M, "Novel minicircle vector for gene therapy in murine myocardial infarction", Circulation, 120(11 Suppl), pp.S230~S237 (2009)
17. Adamopoulos IE, "IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass", J Immunol, 187, pp.951~959 (2011)
18. Lim SW, "Application of minicircle technology of self-reproducing synthetic protein drugs in preventing skin allograft rejection", Ann Transplant, 20, pp.430~440 (2015)
19. Vincenti F, "Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group", N Engl J Med, 338, pp.161~165 (1998)
20. Nashan B, "Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group", Lancet, 350, pp.1193~1198 (1997)
21. Toso C, "Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma", Hepatology, 51, pp.1237~1243 (2010)
22. Tang Q, "Regulatory T-cell therapy in transplantation : moving to the clinic", Cold Spring Harb Perspect Med, 3, pp.a015552~ (2013)
23. Bluestone JA, "The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation", Am J Transplant, 8, pp.2086~2096 (2008)
24. Wood KJ, "Regulatory T cells in transplantation tolerance", Nat Rev Immunol, 3, pp.199~210 (2003)
25. Sakaguchi S, "Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells : their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance", Immunol Rev, 182, pp.18~32 (2001)
26. Jiankuo M, "Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft", J Immunol, 170, pp.1556~1565 (2003)
27. Yi H, "A new strategy to deliver synthetic protein drugs : self-reproducible biologics using minicircles", Sci Rep, 4, pp.5961~ (2014)
28. Kay MA, "A robust system for production of minicircle DNA vectors", Nat Biotechnol, 28, pp.1287~1289 (2010)
29. Herweijer H, "Gene therapy progress and prospects : hydrodynamic gene delivery", Gene Ther, 14, pp.99~107 (2007)
30. McFarland HI, "Skin allograft rejection", Curr Protoc Immunol 2009;Chapter 4:Unit 4.4, ~ (2009)
31. Lim SW, "Host cell in vivo production of the synthetic drug anti-CD25", IL-10 using minicircle vector, 2019, pp.33, 10889~10901
32. Maruyama H, "High-level expression of naked DNA delivered to rat liver via tail vein injection", J Gene Med, 4, pp.333~341 (2002)
33. WolffJA, "The mechanism of naked DNA uptake and expression", Adv Genet, 54, pp.3~20 (2005)
34. Suda T, "Hydrodynamic gene delivery : its principles and applications", Mol Ther, 15, pp.2063~2069 (2007)
35. Zhang X, "In vivo gene delivery via portal vein and bile duct to individual lobes of the rat liver using a polylysine-based nonviral DNA vector in combination with chloroquine", Hum Gene Ther, 12, pp.2179~2190 (2001)
36. Andrianaivo F, "Hydrodynamics-based transfection of the liver : entrance into hepatocytes of DNA that causes expression takes place very early after injection", J Gene Med, 6, pp.877~883 (2004)
37. Kobayashi N, "Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane : implication of a nonspecific process in efficient intracellular gene delivery", J Gene Med, 6, pp.584~592 (2004)
38. Doh KC, "Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression", BMC Complement Altern Med, 19, pp.54~ (2019)
39. Chung BH, "Decrease of immature B cell and interleukin-10 during early-post-transplant period in renal transplant recipients under tacrolimus based immunosuppression", Transpl Immunol, 30, pp.159~167 (2014)
40. Chung BH, "Dysregulation of Th17cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression", PLoS One, 7, pp.e42011~ (2012)
41. Sadlack B, "Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene", Cell, 75, pp.253~261 (1993)
42. Malek TR, "T helper cells, IL-2 and the generation of cytotoxic T-cell responses", Trends Immunol, 23, pp.465~467 (2002)
43. Nelson PJ, "Chemokines, chemokine receptors, and allograft rejection", Immunity, 14, pp.377~386 (2001)
44. Lebranchu Y, "Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy", Am J Transplant, 2, pp.48~56 (2002)
45. Heidt S, "Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help", Clin Exp Immunol, 159, pp.199~207 (2010)
46. Hamawy MM, "Molecular actions of calcineurin inhibitors", Drug News Perspect, 16, pp.277~282 (2003)
47. Ueda H, "Synergy between cyclosporine and anti-IL-2 receptor monoclonal antibodies in rats : functional studies of heart and kidney allografts", Transplantation, 52, pp.437~442 (1991)
48. Ueda H, "The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts", Transplantation, 50, pp.545~550 (1990)
49. Reem GH, "Regulation of interleukin-2 synthesis in human thymocytes", J Biol Response Mod, 3, pp.195~205 (1984)
50. Welte K, "Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes", J Exp Med, 160, pp.1390~1403 (1984)
51. Buscail L, "First-in-man phase 1clinical trial of gene therapy for advanced pancreatic cancer : safety, biodistribution, and preliminary clinical findings", Mol Ther, 23, pp.779~789 (2015)

관련 논문AI추천